Sargent Investment Group’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1K | Sell |
|
|||||
|
2025
Q1 | $21.7K | Sell |
|
|||||
|
2024
Q4 | $38.4K | Sell |
|
|||||
|
2024
Q3 | $284K | Buy |
|
|||||
|
2024
Q2 | $553K | Sell |
|
|||||
|
2024
Q1 | $978K | Sell |
|
|||||
|
2023
Q4 | $825K | Sell |
|
|||||
|
2023
Q3 | $510K | Hold |
|
|||||
|
2023
Q2 | $1.41M | Sell |
|
|||||
|
2023
Q1 | $2.08M | Sell |
|
|||||
|
2022
Q4 | $2.19M | Buy |
|
|||||
|
2022
Q3 | $2.9M | Buy |
|
|||||
|
2022
Q2 | $3.13M | Buy |
|
|||||
|
2022
Q1 | $2.93M | Buy |
|
|||||
|
2021
Q4 | $3.67M | Buy |
|
|||||
|
2021
Q3 | $4.22M | Buy |
|
|||||
|
2021
Q2 | $1.7M | Buy |
|
|||||
|
2021
Q1 | $2.11M | Buy |
|
|||||
|
2020
Q4 | $1.94M | Buy |
|
|||||
|
2020
Q3 | $592K | Buy |
|
|||||
|
2020
Q2 | $246K | Buy |
|
|||||
|
2020
Q1 | $115K | Buy |
|
|||||
|
2019
Q4 | $127K | Buy |
|